ZVRA's three largest insider shareholders as of June 06, 2026 are Neil F. Mcfarlane (President And Ceo, 387.23K shares), R. Laduane Clifton (Cfo Treasurer, 143.51K shares), John B Bode (Director, 123.40K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Tamara A Favorito | - | 3,894 | 0 | 16 Sep, 2025 |
| David S Tierney | - | 10,835 | 0 | 13 Mar, 2023 |
| Richard W Pascoe | Chief Executive Officer | 29,973 | 0 | 13 Mar, 2023 |
| R. Laduane Clifton | Cfo Treasurer | 143,515 | 0 | 07 Jan, 2026 |
| Alvin Shih | - | 20,000 | 0 | 15 Sep, 2025 |
| John B Bode | - | 123,400 | 0 | 26 Mar, 2026 |
| Thomas Anderson | - | 20,000 | 0 | 16 Jul, 2024 |
| Matthew R Plooster | - | 18,500 | 0 | 13 Mar, 2023 |
| Travis C Mickle | President Ceo | 0 | 96,153 | 24 Aug, 2021 |
| Neil F. Mcfarlane | President And Ceo | 387,225 | 0 | 10 Feb, 2026 |
| Timothy J. Sangiovanni | Svp, Finance Corp Controller | 29,590 | 0 | 04 Feb, 2026 |
| Rahsaan Thompson | Chief Legal Compliance | 49,919 | 0 | 02 Feb, 2026 |
| Adrian W Quartel | Chief Medical Officer | 9,723 | 0 | 02 Feb, 2026 |
| Joshua Schafer | Cco | 62,278 | 0 | 04 Feb, 2026 |
| Corey Michael Watton | - | 1,800 | 0 | 31 Mar, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 24 Mar, 2026 | John B Bode | Common Stock | A | 39,200 | $4.97 | 84,200 | D | M |
| 24 Mar, 2026 | John B Bode | Common Stock | A | 39,200 | $4.89 | 123,400 | D | M |
| 24 Mar, 2026 | John B Bode | Stock Option (right to buy) | D | 39,200 | $0.00 | 19,600 | D | M |
| 24 Mar, 2026 | John B Bode | Stock Option (right to buy) | D | 39,200 | $0.00 | 0 | D | M |
| 18 Mar, 2026 | Justin A Renz | Stock Option (right to buy) | A | 300,000 | $0.00 | 300,000 | D | A |
| 07 Feb, 2026 | Neil F. Mcfarlane | Common Stock | A | 37,500 | - | 401,850 | D | M |
| 09 Feb, 2026 | Neil F. Mcfarlane | Common Stock | D | 14,625 | $8.56 | 387,225 | D | S |
| 07 Feb, 2026 | Neil F. Mcfarlane | Restricted Stock Unit | D | 37,500 | $0.00 | 75,000 | D | M |
| 03 Feb, 2026 | Joshua Schafer | Common Stock | D | 10,500 | $9.19 | 62,278 | D | S |
| 03 Feb, 2026 | Timothy J. Sangiovanni | Common Stock | D | 3,000 | $9.18 | 29,590 | D | S |
| 30 Jan, 2026 | Timothy J. Sangiovanni | Common Stock | A | 6,333 | - | 22,674 | D | M |
| 30 Jan, 2026 | Rahsaan Thompson | Common Stock | A | 11,333 | - | 53,999 | D | M |
| 30 Jan, 2026 | Adrian W Quartel | Common Stock | A | 11,333 | - | 14,256 | D | M |
| 30 Jan, 2026 | Joshua Schafer | Common Stock | A | 11,333 | - | 40,819 | D | M |
| 31 Jan, 2026 | Neil F. Mcfarlane | Common Stock | A | 233,334 | - | 455,350 | D | M |
| 30 Jan, 2026 | Adrian W Quartel | Common Stock | D | 4,533 | $8.83 | 9,723 | D | S |
| 02 Feb, 2026 | Neil F. Mcfarlane | Common Stock | D | 91,000 | $9.38 | 364,350 | D | S |
| 30 Jan, 2026 | Rahsaan Thompson | Common Stock | D | 4,080 | $8.83 | 49,919 | D | S |
| 30 Jan, 2026 | Timothy J. Sangiovanni | Common Stock | D | 1,750 | $8.82 | 20,924 | D | S |
| 30 Jan, 2026 | Joshua Schafer | Common Stock | D | 3,375 | $8.83 | 37,444 | D | S |